These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 16272237)
1. Pragmatic, observational study of bupropion treatment for smoking cessation in general practice. Wilkes S; Evans A; Henderson M; Gibson J Postgrad Med J; 2005 Nov; 81(961):719-22. PubMed ID: 16272237 [TBL] [Abstract][Full Text] [Related]
2. Zyban for smoking cessation in a general practice setting: the response to an invitation to make a quit attempt. Johnstone E; Hey K; Drury M; Roberts S; Welch S; Walton R; Murphy M Addict Biol; 2004; 9(3-4):227-32. PubMed ID: 15511717 [TBL] [Abstract][Full Text] [Related]
3. Smoking cessation advice for patients with chronic periodontitis. Nasry HA; Preshaw PM; Stacey F; Heasman L; Swan M; Heasman PA Br Dent J; 2006 Mar; 200(5):272-5; discussion 265. PubMed ID: 16528334 [TBL] [Abstract][Full Text] [Related]
4. Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies? Chatkin JM; Mariante de Abreu C; Haggsträm FM; Wagner MB; Fritscher CC Addiction; 2004 Jun; 99(6):778-84. PubMed ID: 15139876 [TBL] [Abstract][Full Text] [Related]
5. A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees. Dalsgareth OJ; Hansen NC; Søes-Petersen U; Evald T; Høegholm A; Barber J; Vestbo J Nicotine Tob Res; 2004 Feb; 6(1):55-61. PubMed ID: 14982688 [TBL] [Abstract][Full Text] [Related]
6. Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation. Johnston JA; Fiedler-Kelly J; Glover ED; Sachs DP; Grasela TH; DeVeaugh-Geiss J Nicotine Tob Res; 2001 May; 3(2):131-40. PubMed ID: 11403727 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of bupropion therapy for smoking cessation during routine clinical use. Paluck EC; McCormack JP; Ensom MH; Levine M; Soon JA; Fielding DW Ann Pharmacother; 2006 Feb; 40(2):185-90. PubMed ID: 16434561 [TBL] [Abstract][Full Text] [Related]
8. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up. Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of bupropion in the indigenous Maori population in New Zealand. Holt S; Timu-Parata C; Ryder-Lewis S; Weatherall M; Beasley R Thorax; 2005 Feb; 60(2):120-3. PubMed ID: 15681499 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practice. Rovina N; Nikoloutsou I; Katsani G; Dima E; Fransis K; Roussos C; Gratziou C Ther Adv Respir Dis; 2009 Dec; 3(6):279-87. PubMed ID: 19934280 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial. Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642 [TBL] [Abstract][Full Text] [Related]
13. Spirometry and smoking cessation advice in general practice: a randomised clinical trial. Buffels J; Degryse J; Decramer M; Heyrman J Respir Med; 2006 Nov; 100(11):2012-7. PubMed ID: 16580189 [TBL] [Abstract][Full Text] [Related]
14. Smoking cessation treatment in a real-life setting: the Greek experience. Rovina N; Nikoloutsou I; Dima E; Michailidou M; Roussos C; Gratziou C Ther Adv Respir Dis; 2007 Dec; 1(2):93-104. PubMed ID: 19124351 [TBL] [Abstract][Full Text] [Related]
15. Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling. Collins BN; Wileyto EP; Patterson F; Rukstalis M; Audrain-McGovern J; Kaufmann V; Pinto A; Hawk L; Niaura R; Epstein LH; Lerman C Nicotine Tob Res; 2004 Feb; 6(1):27-37. PubMed ID: 14982685 [TBL] [Abstract][Full Text] [Related]
16. A smoking ban in public places increases the efficacy of bupropion and counseling on cessation outcomes at 1 year. Grassi MC; Enea D; Ferketich AK; Lu B; Nencini P Nicotine Tob Res; 2009 Sep; 11(9):1114-21. PubMed ID: 19654237 [TBL] [Abstract][Full Text] [Related]
17. The English smoking treatment services: one-year outcomes. Ferguson J; Bauld L; Chesterman J; Judge K Addiction; 2005 Apr; 100 Suppl 2():59-69. PubMed ID: 15755262 [TBL] [Abstract][Full Text] [Related]
18. Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003. Bolin K; Mörk AC; Willers S; Lindgren B Respir Med; 2008 May; 102(5):699-710. PubMed ID: 18289839 [TBL] [Abstract][Full Text] [Related]
19. Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analyses of clinical trials of Bupropion SR. Scharf D; Shiffman S Addiction; 2004 Nov; 99(11):1462-9. PubMed ID: 15500599 [TBL] [Abstract][Full Text] [Related]
20. Smoking status of Australian general practice patients and their attempts to quit. Doran CM; Valenti L; Robinson M; Britt H; Mattick RP Addict Behav; 2006 May; 31(5):758-66. PubMed ID: 16137834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]